Don Rule

Don Rule

Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products, and integrating Instant Messaging with Voice Over IP networks. Don founded the BioIT Alliance from within Microsoft to accelerate collaboration in translational research.

Read recent posts by this author below »

Finding an Answer in Pharmacogenomics: One Patient’s Journey with PGx Testing

PGx testing has the ability to make a difference in the lives of patients. Here’s one patient story that demonstrates how PGx testing brought her peace of mind.

What New CPIC Guidelines Mean for Pharmacogenetics Implementation

Pharmacogenomics (PGx) has the power to revolutionize health care, save lives, reduce side effects, improve care outcomes, and save money. Illnesses like depression, which have high relapse rates and even higher rates

PGx Testing: Why Success Requires More Than Just Launching a Program

Pharmacogenomic (PGx) testing allows healthcare providers to make more informed, evidence-based decisions for their patients. To take advantage of this new clinical tool, we’ve recently seen several large healthcare

Recent Developments in Pharmacogenomics

For more than a decade, a robust body of evidence has progressively unveiled drug-genome interactions with important implications for health. Yet doctors and many health-care systems have been slow to implement

What You Need To Know About These 3 Newly Approved Drug-Genome Interactions

In 2018, 59 new medications earned FDA approval. Multigene pharmacogenomics (PGx) panels can safely prescribe three of these new drugs to prevent unnecessary toxicities and drug-genome interactions. A decade ago, few